XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Revenue $ 166,797 $ 172,325
Operating expenses:    
Cost of sales 34,360 20,209
Research and development 86,420 84,701
Selling, general and administrative 129,345 129,505
Total operating expenses: 250,125 234,415
Net operating loss (83,328) (62,090)
Interest income 2,658 3,303
Interest expense (11,049) (6,967)
Other (expense)/ income, net (165) (499)
Net loss before taxes (91,884) (66,253)
Income tax expense 341 170
Net loss (92,225) (66,423)
Other comprehensive gain:    
Foreign currency translation 254 17
Total other comprehensive income 254 17
Comprehensive loss, net of tax $ (91,971) $ (66,406)
Net loss per common share, basic $ (0.74) $ (0.54)
Net loss per common share, diluted $ (0.74) $ (0.54)
Weighted-average number of common shares used in net loss per common share, basic 125,452,525 122,956,835
Weighted-average number of common shares used in net loss per common share, diluted 125,452,525 122,956,835
Product revenue, net [Member]    
Revenue:    
Revenue $ 149,900 $ 163,075
Licensing and other revenue [Member]    
Revenue:    
Revenue $ 16,897 $ 9,250